Composition of cefpiramide and sodium glycinate or special solvent composition containing sodium glycinate

A technology of sodium glycinate and cefpiramide, applied in the field of medicine, can solve the problems of slow dissolution, caking, difficult operation, etc., and achieve the effect of improving resistance

Active Publication Date: 2011-09-21
GUANGZHOU BAIYUSN TIANXIN PHARMA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This composition generally has the problem of difficulty in dissolving. When dissolving, there are phenomena such as sticking to the wall, sticking to the bottom, and agglomeration. The dissolving is slow, the dissolving time is long, and the operation is difficult; Irritant symptoms of blood vessels and muscles and thrombophlebitis, such as cord-like red lines along the direction of veins, local tissue redness, swelling, burning, pain, sometimes accompanied by systemic symptoms such as chills and fever
Therefore, it brings great inconvenience to clinical medication, which limits its popularization and application, and has attracted great attention from manufacturers and medical staff.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition of cefpiramide and sodium glycinate or special solvent composition containing sodium glycinate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] The composition of embodiment 1 cefpiramide and sodium glycinate

[0026] Weigh 150.0 g of cefpiramide, mix it with 22.8 g of sodium glycinate, and after mixing for 1 hour, pack it according to the specification of 0.5 g / bottle, and squeeze the cap to get it.

Embodiment 2

[0027] The composition of embodiment 2 cefpiramide and sodium glycinate

[0028] Weigh 150.0 g of cefpiramide, mix it with 24.9 g of sodium glycinate, and after mixing for 1 hour, pack it according to the specification of 0.5 g / bottle, and squeeze the cap to get it.

Embodiment 3

[0029] The composition of embodiment 3 cefpiramide and sodium glycinate

[0030] Weigh 100.0 g of cefpiramide, mix it with 18.1 g of sodium glycinate, and after mixing for 1 hour, pack it according to the specification of 0.5 g / bottle, and squeeze the cap to get it.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a composition of cefpiramide and sodium glycinate or a special solvent composition containing sodium glycinate. The invention is used for pharmacy. The weight ratio of the cefpiramide to the sodium glycinate is 1:0.152-0.210 and the solvent composition is specially used for injection. A bottle of 0.5g of cefpiramide is mixed with 2-10ml of solvent, and a bottle of 1g of cefpiramide is mixed with 5-20ml of solvent. The cefpiramide is easy to dissolve, and the invention is safe to inject, can provide amino acid indispensible to human body and improve the immunity of thepatients, and is simple and convenient to operate.

Description

technical field [0001] The invention belongs to the technical field of medicine and relates to cefpiramide (Cefpiramide), namely 7-[2-[(4-hydroxy-6-methylpyridine-3-carbonyl)-amino]-2-(4-hydroxyphenyl)- Acetylamino]-3-(1-methyl-1H-tetrazole-5-thiomethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene -The composition of 2-carboxylic acid and sodium glycinate or the solvent combination specially used for injection cefpiramide containing sodium glycinate. technical background [0002] This strain is a semi-synthetic third-generation cephalosporin antibiotic. After the drug was launched in Japan in 1985, it has been widely used in the clinical treatment of bacterial infections, and achieved good curative effect, with rare and mild adverse reactions. This product is characterized by broad antibacterial spectrum and bactericidal power, strong antibacterial activity against Gram-positive bacteria, negative bacteria and anaerobic bacteria, and quite stable against β-lactamase. Clinic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/198A61K47/18A61K31/546A61P31/04A61P3/02
Inventor 谭胜连司徒小燕陈大为
Owner GUANGZHOU BAIYUSN TIANXIN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products